Circassia Pharmaceuticals PLC (LSE:CIR) - Overview

Stock Report

Circassia Pharmaceuticals PLC CIR

Last Price
GBX90.50

Day Change
2.50|2.84%

As of 08/12/2016
16:35:21 GMT | GBX
Minimum 15 Minutes Delay.

Last Close88.00p
Day Range85.75 - 90.50
Mkt Cap250.70Mil
52-Wk Range78.45 - 322.90
Yield %0.00
ISINGB00BJVD3B28
Volume111,113
P/E-4.53
P/S20.92
P/CF-4.28

Share Price

Total Returns 08/12/2016

 Chg (%)  
More ...
Circassia Pharmaceuticals PLC13.13 
FTSE 100 TR GBP1.82
 
Financials
201320142015
More ...
Income Statement
Turnover0.000.0010.80
Operating Profit-24.53-45.80-66.40
Net Profit-19.98-35.10-50.00
Reported EPS-10.70-21.00-20.00
Balance Sheet
Current Assets35.83198.10223.70
Non Current Assets2.212.40265.50
Total Assets38.03200.50489.20
Current Liabilities7.999.7048.30
Total Liabilities7.999.7079.50
Total Equity30.05190.80409.70
Cash Flow
Operating Cash Flow-22.17-41.00-64.90
Net Change in Cash9.305.70135.70
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-67.60-19.74--4.46---
2017-34.48-10.01--8.79---

Company Profile

Circassia Pharmaceuticals PLC is a clinical-stage specialty biopharmaceutical company engaged in the development and commercialisation of a range of allergy, asthma and respiratory products.
 

Sector

Biotechnology

Market Position

610 of 1865 Companies

Index

FTSE Small Cap ,FTSE All Share

Outlook

(27/09/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-8.2613.1215.86
Div Yld (E)0.004.254.26
PEG (E)0.000.200.15
ROCE-32.35209.39-30.49
Op Mrgn-598.15-16.09-33.54
EPS Grwth0.0010.0923.13
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy2
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Francesco Granata
Chief Executive OfficerMr. Steven Harris
Chief Financial Officer & Company SecretJulien Cotta
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.